Evidence map›Paper›PMID 41856929›Full record

ArticleJournal of chemical information and modeling2026

LiBRe: A Ligand-Aware Sequence-Based Binding Residue Prediction Model for Virtual Screening.

Keumseok Kang, Mingyeol Kim, Juseong Kim, Sanghun Sel, Giltae Song

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keumseok KangDivision of Artificial Intelligence, Pusan National University, 2 Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Mingyeol KimDivision of Artificial Intelligence, Pusan National University, 2 Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Juseong KimDivision of Artificial Intelligence, Pusan National University, 2 Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Sanghun SelDivision of Artificial Intelligence, Pusan National University, 2 Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Giltae SongDivision of Artificial Intelligence, Pusan National University, 2 Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.ORCID 0000-0001-8796-4678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying protein-ligand binding residues is fundamental to unlocking molecular recognition and advancing therapeutic development. Sequence-based deep learning models for predicting protein-ligand binding residues have gained attention due to their scalability and ability to operate without relying on structural information. However, most existing methods primarily focus on protein sequence information without considering ligand information, even though binding residues are inherently defined through interactions with specific ligands. To address this, we propose a ligand-aware sequence-based binding residue prediction model that explicitly incorporates both residue-level information from protein sequences and ligand information. The proposed model achieved significant improvements in the prediction of ligand-binding residues, outperforming both existing sequence-based and structure-based baselines. Furthermore, pockets defined by the ligand-binding residues predicted by our model led to a stronger and more stable binding affinity compared to existing tools. These results demonstrate that our model shows significant potential for applications in virtual screening and drug discovery. Our source code is publicly available at https://github.com/GoldRiver0/LiBRe.

Indexed as

ProteinsSoftwareAmino Acid SequenceBinding SitesDrug Evaluation, PreclinicalLigandsModels, MolecularProtein BindingLigandsProteins

Identifiers

PMID41856929
PMCPMC13080968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.